Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Physicist Gets Over 1.5 Million (Euros) to Research Tumors

August 2, 2016 By Forschungsverbund Berlin e.V. (FVB)

The physicist Leif Schröder has been granted funding totaling 1.525 million euros in the Koselleck program of the Deutsche Forschungsgemeinschaft (DFG) for highly innovative research into the detection of tumors.

The Leibniz-Institut für Molekulare Pharmakologie (FMP) and the Leibniz-Gemeinschaft have their first Koselleck grantee: Leif Schröder is conducting research on a novel, non-invasive diagnostic imaging procedure. The well-known magnetic resonance imaging (MRI) plays a key role here, although it is normally limited to the detection of relatively highly concentrated molecules. That’s the main challenge of this diagnostic method, which is otherwise sparing for the patient.

The method of spin hyperpolarization is now to be applied to harness the majority of the previously largely unused potential (>99.9 percent), in order to visualize weakly concentrated molecules as well. Challenges remain with respect to the rapid attenuation of the hyperpolarization and detection in tissue.

Leif Schröder and his group use biosensors to trace desired target molecules and then combine them with the hyperpolarized atoms on living cells. The additional combination with the inert gas xenon makes the biosensors into highly sensitive detectives that identify target molecules at million-fold reduced acquisition times.

For the Koselleck research project, the group is now interested in biosensor detection in living tissue, an experiment that hasn’t yet been achieved anywhere in the world.

“But that will soon change. In our interdisciplinary Koselleck project, we will achieve the development of novel nanocarriers that will be able to take up a large number of hyperpolarised atoms in the tissue,” Schröder said.

The objective of the research project is to visualize sophisticated biomarkers, such as cell surface glycans. These glucose compounds contain valuable diagnostic information about the malignancy of tumors.

Leif Schröder convinced the Deutsche Forschungsgemeinschaft (DFG) with his project application, which it acknowledged as an “exceptionally innovative project that is high-risk in a positive sense.” The success of this project would represent a “quantum leap” in medical diagnostics, as is further stated in the appraisal.

Schröder’s project is regarded by the DFG as a “prime example for the Koselleck program,” which is designed to give researchers appropriate flexibility and time to attempt major breakthroughs.

The research group will receive 1.525 million euros for a period of five years, which will be supplemented by a further commitment of the FMP in this field. 

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech